177 related articles for article (PubMed ID: 19569163)
1. Chemistry and pharmacology of nicotinic ligands based on 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol (AMOP-H-OH) for possible use in depression.
Kozikowski AP; Eaton JB; Bajjuri KM; Chellappan SK; Chen Y; Karadi S; He R; Caldarone B; Manzano M; Yuen PW; Lukas RJ
ChemMedChem; 2009 Aug; 4(8):1279-91. PubMed ID: 19569163
[TBL] [Abstract][Full Text] [Related]
2. Chemistry and pharmacological characterization of novel nitrogen analogues of AMOP-H-OH (Sazetidine-A, 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol) as α4β2-nicotinic acetylcholine receptor-selective partial agonists.
Liu J; Eaton JB; Caldarone B; Lukas RJ; Kozikowski AP
J Med Chem; 2010 Oct; 53(19):6973-85. PubMed ID: 20822184
[TBL] [Abstract][Full Text] [Related]
3. Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380.
Caldarone BJ; Wang D; Paterson NE; Manzano M; Fedolak A; Cavino K; Kwan M; Hanania T; Chellappan SK; Kozikowski AP; Olivier B; Picciotto MR; Ghavami A
Psychopharmacology (Berl); 2011 Sep; 217(2):199-210. PubMed ID: 21487659
[TBL] [Abstract][Full Text] [Related]
4. Sazetidine-A is a potent and selective agonist at native and recombinant alpha 4 beta 2 nicotinic acetylcholine receptors.
Zwart R; Carbone AL; Moroni M; Bermudez I; Mogg AJ; Folly EA; Broad LM; Williams AC; Zhang D; Ding C; Heinz BA; Sher E
Mol Pharmacol; 2008 Jun; 73(6):1838-43. PubMed ID: 18367540
[TBL] [Abstract][Full Text] [Related]
5. Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them.
Xiao Y; Fan H; Musachio JL; Wei ZL; Chellappan SK; Kozikowski AP; Kellar KJ
Mol Pharmacol; 2006 Oct; 70(4):1454-60. PubMed ID: 16857741
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacological characterization of new neuronal nicotinic acetylcholine receptor ligands derived from Sazetidine-A.
Liu Y; Paige M; Olson TT; Al-Muhtasib N; Xie T; Hou S; White MP; Cordova A; Guo JL; Kellar KJ; Xiao Y; Brown ML
Bioorg Med Chem Lett; 2014 Jul; 24(13):2954-6. PubMed ID: 24844195
[TBL] [Abstract][Full Text] [Related]
7. Recent developments in novel antidepressants targeting α4β2-nicotinic acetylcholine receptors.
Yu LF; Zhang HK; Caldarone BJ; Eaton JB; Lukas RJ; Kozikowski AP
J Med Chem; 2014 Oct; 57(20):8204-23. PubMed ID: 24901260
[TBL] [Abstract][Full Text] [Related]
8. Discovery of isoxazole analogues of sazetidine-A as selective α4β2-nicotinic acetylcholine receptor partial agonists for the treatment of depression.
Liu J; Yu LF; Eaton JB; Caldarone B; Cavino K; Ruiz C; Terry M; Fedolak A; Wang D; Ghavami A; Lowe DA; Brunner D; Lukas RJ; Kozikowski AP
J Med Chem; 2011 Oct; 54(20):7280-8. PubMed ID: 21905669
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptors.
Carroll FI; Navarro HA; Mascarella SW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Jackson A; Damaj MI
ACS Chem Neurosci; 2015 Jun; 6(6):920-6. PubMed ID: 25891987
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes.
Arias HR; Feuerbach D; Targowska-Duda K; Kaczor AA; Poso A; Jozwiak K
Biochim Biophys Acta; 2015 Feb; 1848(2):731-41. PubMed ID: 25475645
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests.
Andreasen JT; Olsen GM; Wiborg O; Redrobe JP
J Psychopharmacol; 2009 Sep; 23(7):797-804. PubMed ID: 18583432
[TBL] [Abstract][Full Text] [Related]
12. Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors.
Wu J; Liu Q; Yu K; Hu J; Kuo YP; Segerberg M; St John PA; Lukas RJ
J Physiol; 2006 Oct; 576(Pt 1):103-18. PubMed ID: 16825297
[TBL] [Abstract][Full Text] [Related]
13. The antinociceptive effects of nicotinic partial agonists varenicline and sazetidine-A in murine acute and tonic pain models.
AlSharari SD; Carroll FI; McIntosh JM; Damaj MI
J Pharmacol Exp Ther; 2012 Sep; 342(3):742-9. PubMed ID: 22678099
[TBL] [Abstract][Full Text] [Related]
14. Effects of prolonged nicotinic ligand exposure on function of heterologously expressed, human alpha4beta2- and alpha4beta4-nicotinic acetylcholine receptors.
Gentry CL; Wilkins LH; Lukas RJ
J Pharmacol Exp Ther; 2003 Jan; 304(1):206-16. PubMed ID: 12490593
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and discovery of picomolar selective α4β2 nicotinic acetylcholine receptor ligands.
Yenugonda VM; Xiao Y; Levin ED; Rezvani AH; Tran T; Al-Muhtasib N; Sahibzada N; Xie T; Wells C; Slade S; Johnson JE; Dakshanamurthy S; Kong HS; Tomita Y; Liu Y; Paige M; Kellar KJ; Brown ML
J Med Chem; 2013 Nov; 56(21):8404-21. PubMed ID: 24047231
[TBL] [Abstract][Full Text] [Related]
16. An Accessory Agonist Binding Site Promotes Activation of α4β2* Nicotinic Acetylcholine Receptors.
Wang J; Kuryatov A; Sriram A; Jin Z; Kamenecka TM; Kenny PJ; Lindstrom J
J Biol Chem; 2015 May; 290(22):13907-18. PubMed ID: 25869137
[TBL] [Abstract][Full Text] [Related]
17. Pyrrolidinyl benzofurans and benzodioxanes: Selective α4β2 nicotinic acetylcholine receptor ligands with different activity profiles at the two receptor stoichiometries.
Appiani R; Pallavicini M; Hamouda AK; Bolchi C
Bioorg Med Chem Lett; 2022 Jun; 65():128701. PubMed ID: 35346843
[TBL] [Abstract][Full Text] [Related]
18. The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data.
Rollema H; Hurst RS
Psychopharmacology (Berl); 2018 Sep; 235(9):2479-2505. PubMed ID: 29980822
[TBL] [Abstract][Full Text] [Related]
19. Discovery of an intrasubunit nicotinic acetylcholine receptor-binding site for the positive allosteric modulator Br-PBTC.
Norleans J; Wang J; Kuryatov A; Leffler A; Doebelin C; Kamenecka TM; Lindstrom J
J Biol Chem; 2019 Aug; 294(32):12132-12145. PubMed ID: 31221718
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, Nicotinic Acetylcholine Binding, and in Vitro and in Vivo Pharmacological Properties of 2'-Fluoro-(carbamoylpyridinyl)deschloroepibatidine Analogues.
Ondachi PW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Damaj MI; Mascarella SW; Navarro HA; Carroll FI
ACS Chem Neurosci; 2016 Jul; 7(7):1004-12. PubMed ID: 27166021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
